Novonesis (Novozymes) B Class B NSIS B

Morningstar Rating
DKK 451.40 +0.80 (0.18%)
View Full Chart

Company Report

Price vs Fair Value

NSIS B is trading at a LOCK|@P&^^@$ premium.
Price
DKK 450.60
Fair Value
<s<
Uncertainty
LOCK|#<yl!
1-Star Price
D!f
5-Star Price
LOCK|hZ
Economic Moat
LOCK|bph
Capital Allocation
LOCK|J$dB>V

Bulls Say, Bears Say

Bulls

Novonesis holds a dominant market position in enzymes and cultures, with nearly 50% market share in both, supported by an enviable portfolio of patents and an unmatched library of strains and enzyme classes.

Bears

Novonesis' core markets offer relatively low growth prospects, which means the company is now relying more on new markets and inorganic growth initiatives.

Trading Information

Previous Close Price
DKK 450.60
Day Range
DKK 450.50–455.60
52-Week Range
DKK 336.80–484.70
Bid/Ask
DKK 452.30 / DKK 452.50
Shares Outstanding
466.11M
Market Cap
DKK 210.40B
Volume/Avg
709,354 / 651,418

Key Statistics

Price/Earnings (Normalized)
31.16
Price/Sales
6.46
Dividend Yield (Trailing)
1.46%
Dividend Yield (Forward)
1.46%
Dividend Payment Schedule
Mar, Aug
Total Yield
1.46%

Company Profile

Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs more than 11,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.
Sector
Basic Materials
Industry
Specialty Chemicals
Stock Style Box
Large Growth
Total Number of Employees
11,641

Competitors

Valuation

Metric
NSIS B
IFF
GIVN
Price/Earnings (Normalized)
31.1631.9237.67
Price/Book Value
2.511.518.54
Price/Sales
6.462.435.11
Price/Cash Flow
20.8716.4125.92
Price/Earnings
NSIS B
IFF
GIVN

Financial Strength

Metric
NSIS B
IFF
GIVN
Quick Ratio
0.960.370.70
Current Ratio
1.531.871.29
Interest Coverage
13.71−4.0610.87
Quick Ratio
NSIS B
IFF
GIVN

Profitability

Metric
NSIS B
IFF
GIVN
Return on Assets (Normalized)
5.88%2.69%9.24%
Return on Equity (Normalized)
8.85%4.87%24.97%
Return on Invested Capital (Normalized)
7.28%4.00%12.86%
Return on Assets
NSIS B
IFF
GIVN

Specialty Chemicals Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Linde PLC
LIN
LOCK|<FQwj^sXLOCK|Vv$240B
Ecolab Inc
ECL
LOCK|!#y$yGwLOCK|JjC$86B
Sherwin-Williams Co
SHW
LOCK|qCmYq@MmLOCK|?#$85B
Air Products and Chemicals Inc
APD
LOCK|K#%!$%gLOCK|^l$70B
PPG Industries Inc
PPG
LOCK|F!!>!rLOCK|%X?%$27B
International Flavors & Fragrances Inc
IFF
LOCK|JgXb%&!LOCK|%kflX$20B
LyondellBasell Industries NV Class A
LYB
LOCK|#w#DjgFLOCK|?^q!$$20B
DuPont de Nemours Inc
DD
LOCK|>kV@#y!LOCK|?f%l$20B
Sociedad Quimica Y Minera De Chile SA ADR
SQM
LOCK|gB?%T$LOCK|lZ!@b$15B
Albemarle Corp
ALB
LOCK|Y<tR&%LOCK|k&tt$10B

Sponsor Center